System Dynamics Modeling Can be Leveraged to Predict Critical Care Pathways and Costs for End Stage Renal Disease: US Population to 2020
**Background:** End Stage Renal Disease (ESRD) accounts for 9% of Medicare spending, with the beneficiaries suffering from ESRD costing 7-9 times more than the average. This population is expected to continue to grow as a portion of Medicare beneficiaries. To provide clinicians and administrators wi...
Saved in:
Main Authors: | Luca Fernandez, Christopher Koliba, Asim Zia, Katharine Cheung, Richard Solomon, Christopher Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2015-07-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9839 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Leveraging Technology “Save” Physical Therapy?
by: Reuben Gobezie
Published: (2023-08-01) -
Tumour Calcification and Calciphylaxis in End-Stage Renal Disease
by: Jia Di, et al.
Published: (2014-01-01) -
The NT-ProBNP Test in Subjects with End-Stage Renal Disease on Hemodialysis Presenting with Acute Dyspnea: Is Knowing Worth the Cost?
by: Shaffer R. S. Mok, et al.
Published: (2013-01-01) -
Prosthetic Aortic Valve Stenosis in End-Stage Renal Failure
by: Michael Mao, et al.
Published: (2011-01-01) -
Dyslipidemia among Patients with End Stage Renal Disease on Maintenance Hemodialysis
by: Mohammed Ghazi Abdulhadi, et al.
Published: (2018-07-01)